CHR-3996

· Chroma Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHR-3996, covering 2011-11-28 to 2011-11-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours [Phase 1]